Financial Consulate’s PharmaCyte Biotech PMCB Stock Holding History

Financial Consulate’s Portfolio PMCB Stock Details PMCB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1	Hold	2	–	–	﹤0.01%	1896
2026 Q2	$2	Hold	2	–	–	﹤0.01%	1448
2026 Q1	$2	Hold	2	–	–	﹤0.01%	1401
2025 Q4	$2	Hold	2	–	–	﹤0.01%	1338
2025 Q3	$2	Buy	+2	New	+$2	﹤0.01%	1151

Financial Consulate's PMCB Position: Q3 2026 in Review

Financial Consulate held its PharmaCyte Biotech (PMCB) position steady in Q3 2026 at 2 shares worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1896.

Financial Consulate first reported a position in PMCB in Q3 2025 and has held it in 5 quarters since. The position peaked at $2 in Q2 2026. 1 fund tracked by Wall St. Rank holds PMCB as of Q3 2026.

Financial Consulate held 2 shares of PharmaCyte Biotech worth $1 as of Q3 2026.
Financial Consulate left its PharmaCyte Biotech share count unchanged in Q3 2026.
PharmaCyte Biotech made up ﹤0.01% of Financial Consulate's portfolio in Q3 2026, its #1896 holding.
Financial Consulate first reported a position in PharmaCyte Biotech in Q3 2025 and has held it in 5 quarters since.
Financial Consulate's PharmaCyte Biotech position peaked at $2 in Q2 2026.
1 fund tracked by Wall St. Rank held PharmaCyte Biotech as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.